Zinc in PDB 7js8: Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22)
Enzymatic activity of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22)
All present enzymatic activity of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22):
3.5.1.98;
Protein crystallography data
The structure of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22), PDB code: 7js8
was solved by
D.J.Klein,
W.Yu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
23.60 /
1.63
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
92.43,
99.16,
139.65,
90,
90,
90
|
R / Rfree (%)
|
16.7 /
19
|
Other elements in 7js8:
The structure of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22) also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22)
(pdb code 7js8). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 3 binding sites of Zinc where determined in the
Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22), PDB code: 7js8:
Jump to Zinc binding site number:
1;
2;
3;
Zinc binding site 1 out
of 3 in 7js8
Go back to
Zinc Binding Sites List in 7js8
Zinc binding site 1 out
of 3 in the Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22)
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn401
b:16.7
occ:1.00
|
OD2
|
A:ASP265
|
1.9
|
16.5
|
1.0
|
OD1
|
A:ASP177
|
2.0
|
16.1
|
1.0
|
ND1
|
A:HIS179
|
2.0
|
16.3
|
1.0
|
O1
|
A:VJV411
|
2.1
|
18.9
|
1.0
|
O
|
A:VJV411
|
2.5
|
17.7
|
1.0
|
C2
|
A:VJV411
|
2.8
|
19.7
|
1.0
|
CG
|
A:ASP177
|
2.8
|
15.4
|
1.0
|
CG
|
A:ASP265
|
2.9
|
15.6
|
1.0
|
CE1
|
A:HIS179
|
2.9
|
17.2
|
1.0
|
OD2
|
A:ASP177
|
3.0
|
16.8
|
1.0
|
CG
|
A:HIS179
|
3.1
|
15.8
|
1.0
|
OD1
|
A:ASP265
|
3.3
|
14.7
|
1.0
|
CB
|
A:HIS179
|
3.5
|
15.5
|
1.0
|
C1
|
A:VJV411
|
3.8
|
21.2
|
1.0
|
N
|
A:HIS179
|
3.8
|
14.8
|
1.0
|
C3
|
A:VJV411
|
3.9
|
20.4
|
1.0
|
C4
|
A:VJV411
|
3.9
|
20.9
|
1.0
|
CA
|
A:GLY302
|
4.0
|
15.9
|
1.0
|
NE2
|
A:HIS179
|
4.1
|
17.4
|
1.0
|
CG2
|
A:ILE178
|
4.1
|
14.9
|
1.0
|
CB
|
A:ASP177
|
4.2
|
14.5
|
1.0
|
CD2
|
A:HIS179
|
4.2
|
16.4
|
1.0
|
CB
|
A:ASP265
|
4.2
|
15.9
|
1.0
|
N
|
A:ILE178
|
4.3
|
13.5
|
1.0
|
CA
|
A:HIS179
|
4.3
|
15.1
|
1.0
|
OH
|
A:TYR304
|
4.3
|
17.0
|
1.0
|
CE2
|
A:TYR304
|
4.4
|
15.8
|
1.0
|
NE2
|
A:HIS141
|
4.4
|
18.2
|
1.0
|
N
|
A:GLY302
|
4.4
|
15.3
|
1.0
|
C
|
A:ILE178
|
4.8
|
15.7
|
1.0
|
CZ
|
A:TYR304
|
4.9
|
16.4
|
1.0
|
C
|
A:VJV411
|
4.9
|
21.7
|
1.0
|
CE1
|
A:HIS141
|
4.9
|
18.5
|
1.0
|
C
|
A:ASP177
|
4.9
|
14.7
|
1.0
|
CA
|
A:ASP177
|
4.9
|
13.8
|
1.0
|
NE2
|
A:HIS142
|
4.9
|
17.7
|
1.0
|
CA
|
A:ILE178
|
5.0
|
14.3
|
1.0
|
|
Zinc binding site 2 out
of 3 in 7js8
Go back to
Zinc Binding Sites List in 7js8
Zinc binding site 2 out
of 3 in the Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22)
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn401
b:15.4
occ:1.00
|
OD2
|
B:ASP265
|
1.9
|
16.1
|
1.0
|
OD1
|
B:ASP177
|
2.0
|
14.4
|
1.0
|
ND1
|
B:HIS179
|
2.0
|
13.7
|
1.0
|
O
|
B:VJV408
|
2.0
|
17.5
|
1.0
|
O1
|
B:VJV408
|
2.5
|
16.4
|
1.0
|
C2
|
B:VJV408
|
2.7
|
17.9
|
1.0
|
CG
|
B:ASP177
|
2.8
|
15.5
|
1.0
|
CE1
|
B:HIS179
|
2.9
|
15.3
|
1.0
|
CG
|
B:ASP265
|
2.9
|
15.0
|
1.0
|
OD2
|
B:ASP177
|
3.0
|
14.9
|
1.0
|
CG
|
B:HIS179
|
3.1
|
14.5
|
1.0
|
OD1
|
B:ASP265
|
3.3
|
13.6
|
1.0
|
CB
|
B:HIS179
|
3.6
|
13.7
|
1.0
|
C1
|
B:VJV408
|
3.8
|
19.6
|
1.0
|
N
|
B:HIS179
|
3.8
|
13.5
|
1.0
|
C3
|
B:VJV408
|
3.8
|
18.5
|
1.0
|
C4
|
B:VJV408
|
3.9
|
18.8
|
1.0
|
CA
|
B:GLY302
|
4.0
|
14.2
|
1.0
|
NE2
|
B:HIS179
|
4.1
|
16.3
|
1.0
|
CG2
|
B:ILE178
|
4.2
|
13.9
|
1.0
|
CD2
|
B:HIS179
|
4.2
|
15.6
|
1.0
|
CB
|
B:ASP177
|
4.2
|
13.3
|
1.0
|
CB
|
B:ASP265
|
4.3
|
14.2
|
1.0
|
CA
|
B:HIS179
|
4.3
|
13.4
|
1.0
|
OH
|
B:TYR304
|
4.3
|
16.1
|
1.0
|
N
|
B:ILE178
|
4.4
|
11.5
|
1.0
|
CE2
|
B:TYR304
|
4.4
|
14.5
|
1.0
|
N
|
B:GLY302
|
4.4
|
13.0
|
1.0
|
NE2
|
B:HIS141
|
4.4
|
16.8
|
1.0
|
C
|
B:VJV408
|
4.8
|
20.0
|
1.0
|
C
|
B:ILE178
|
4.8
|
13.3
|
1.0
|
CZ
|
B:TYR304
|
4.9
|
14.2
|
1.0
|
CE1
|
B:HIS141
|
4.9
|
17.1
|
1.0
|
C
|
B:ASP177
|
4.9
|
12.8
|
1.0
|
CA
|
B:ASP177
|
4.9
|
12.5
|
1.0
|
NE2
|
B:HIS142
|
5.0
|
17.2
|
1.0
|
CA
|
B:ILE178
|
5.0
|
12.1
|
1.0
|
|
Zinc binding site 3 out
of 3 in 7js8
Go back to
Zinc Binding Sites List in 7js8
Zinc binding site 3 out
of 3 in the Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22)
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Structure of Human HDAC2 in Complex with An Ethyl Ketone Inhibitor Containing A Spiro-Bicyclic Group (Compound 22) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn401
b:21.2
occ:1.00
|
OD1
|
C:ASP177
|
1.9
|
18.7
|
1.0
|
OD2
|
C:ASP265
|
2.0
|
21.6
|
1.0
|
ND1
|
C:HIS179
|
2.0
|
21.7
|
1.0
|
O1
|
C:VJV410
|
2.1
|
23.1
|
1.0
|
O
|
C:VJV410
|
2.5
|
21.6
|
1.0
|
CG
|
C:ASP177
|
2.8
|
19.9
|
1.0
|
C2
|
C:VJV410
|
2.8
|
23.3
|
1.0
|
CG
|
C:ASP265
|
2.9
|
22.2
|
1.0
|
CE1
|
C:HIS179
|
3.0
|
21.6
|
1.0
|
OD2
|
C:ASP177
|
3.0
|
21.1
|
1.0
|
CG
|
C:HIS179
|
3.1
|
19.4
|
1.0
|
OD1
|
C:ASP265
|
3.2
|
21.3
|
1.0
|
CB
|
C:HIS179
|
3.5
|
18.9
|
1.0
|
N
|
C:HIS179
|
3.8
|
19.0
|
1.0
|
C1
|
C:VJV410
|
3.8
|
24.2
|
1.0
|
C3
|
C:VJV410
|
3.9
|
23.6
|
1.0
|
C4
|
C:VJV410
|
3.9
|
24.6
|
1.0
|
CA
|
C:GLY302
|
4.0
|
21.5
|
1.0
|
NE2
|
C:HIS179
|
4.2
|
21.0
|
1.0
|
CG2
|
C:ILE178
|
4.2
|
20.9
|
1.0
|
CB
|
C:ASP177
|
4.2
|
19.9
|
1.0
|
CD2
|
C:HIS179
|
4.2
|
19.8
|
1.0
|
OH
|
C:TYR304
|
4.3
|
23.1
|
1.0
|
CB
|
C:ASP265
|
4.3
|
21.1
|
1.0
|
CA
|
C:HIS179
|
4.3
|
18.7
|
1.0
|
N
|
C:ILE178
|
4.3
|
19.5
|
1.0
|
CE2
|
C:TYR304
|
4.4
|
24.1
|
1.0
|
NE2
|
C:HIS141
|
4.4
|
22.5
|
1.0
|
N
|
C:GLY302
|
4.4
|
21.0
|
1.0
|
C
|
C:ILE178
|
4.8
|
19.4
|
1.0
|
CZ
|
C:TYR304
|
4.8
|
24.6
|
1.0
|
C
|
C:VJV410
|
4.9
|
24.7
|
1.0
|
CE1
|
C:HIS141
|
4.9
|
22.8
|
1.0
|
C
|
C:ASP177
|
4.9
|
20.1
|
1.0
|
CA
|
C:ASP177
|
4.9
|
20.0
|
1.0
|
NE2
|
C:HIS142
|
5.0
|
21.1
|
1.0
|
CA
|
C:ILE178
|
5.0
|
19.3
|
1.0
|
|
Reference:
W.Yu,
J.Liu,
D.Clausen,
Y.Yu,
J.L.Duffy,
M.Wang,
S.Xu,
L.Deng,
T.Suzuki,
C.C.Chung,
R.W.Myers,
D.J.Klein,
J.I.Fells,
M.K.Holloway,
J.Wu,
G.Wu,
B.J.Howell,
R.J.O.Barnard,
J.Kozlowski.
Discovery of Ethyl Ketone-Based Highly Selective Hdacs 1, 2, 3 Inhibitors For Hiv Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced Herg Activity. J.Med.Chem. V. 64 4709 2021.
ISSN: ISSN 0022-2623
PubMed: 33797924
DOI: 10.1021/ACS.JMEDCHEM.0C02150
Page generated: Tue Oct 29 21:04:09 2024
|